September 2023 Editor’s Choice: Is now the time to begin thromboprophylaxis for all patients with advanced ovarian cancer, including those undergoing neoadjuvant chemotherapy?
Update: 2023-10-27
Description
Editor’s Choice Paper:
Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?
Editorial: Universal thromboprophylaxis in ovarian cancer patients before and after surgery?
Hosted by:
David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology
Featuring:
Amanika Kumar, MD, Mayo Clinic
Laura Havrilesky, MD, Duke University 
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
